Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

C. Theodore; L. Geoffrois; J.B. Vermorken; F. Caponigro; W. Fiedler; P. Chollet; A. Ravaud; G.J. Peters; C. de Balincourt; D Lacombe; P Fumoleau

doi:https://doi.org/10.1016/j.ejca.2005.02.015

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

C. Theodore, L. Geoffrois, J.B. Vermorken, F. Caponigro, W. Fiedler, P. Chollet, A. Ravaud, G.J. Peters, C. de Balincourt, D Lacombe, P Fumoleau

Amsterdam UMC

Research output: Contribution to journal › Article › Academic › peer-review

51 Citations (Scopus)

Original language	English
Pages (from-to)	1150-1157
Journal	European Journal of Cancer
Volume	41
Issue number	8
DOIs	https://doi.org/10.1016/j.ejca.2005.02.015
Publication status	Published - 2005

Access to Document

https://doi.org/10.1016/j.ejca.2005.02.015

Cite this

Theodore, C., Geoffrois, L., Vermorken, J. B., Caponigro, F., Fiedler, W., Chollet, P., Ravaud, A., Peters, G. J., de Balincourt, C., Lacombe, D., & Fumoleau, P. (2005). Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. European Journal of Cancer, 41(8), 1150-1157. https://doi.org/10.1016/j.ejca.2005.02.015

@article{5c3179e35df347a09a98a804cd3ec5b7,

title = "Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers",

author = "C. Theodore and L. Geoffrois and J.B. Vermorken and F. Caponigro and W. Fiedler and P. Chollet and A. Ravaud and G.J. Peters and {de Balincourt}, C. and D Lacombe and P Fumoleau",

year = "2005",

doi = "https://doi.org/10.1016/j.ejca.2005.02.015",

language = "English",

volume = "41",

pages = "1150--1157",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "8",

}

Theodore, C, Geoffrois, L, Vermorken, JB, Caponigro, F, Fiedler, W, Chollet, P, Ravaud, A, Peters, GJ, de Balincourt, C, Lacombe, D & Fumoleau, P 2005, 'Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers', European Journal of Cancer, vol. 41, no. 8, pp. 1150-1157. https://doi.org/10.1016/j.ejca.2005.02.015

Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. / Theodore, C.; Geoffrois, L.; Vermorken, J.B. et al.
In: European Journal of Cancer, Vol. 41, No. 8, 2005, p. 1150-1157.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers

AU - Theodore, C.

AU - Geoffrois, L.

AU - Vermorken, J.B.

AU - Caponigro, F.

AU - Fiedler, W.

AU - Chollet, P.

AU - Ravaud, A.

AU - Peters, G.J.

AU - de Balincourt, C.

AU - Lacombe, D

AU - Fumoleau, P

PY - 2005

Y1 - 2005

U2 - https://doi.org/10.1016/j.ejca.2005.02.015

DO - https://doi.org/10.1016/j.ejca.2005.02.015

M3 - Article

SN - 0959-8049

VL - 41

SP - 1150

EP - 1157

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 8

ER -